Dual inhibition of PKC and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma

被引：0
|
作者：
Carita, Guillaume
Leitz, Estelle Frisch Dit
Dahmani, Ahmed
Raymondie, Chloe
Cassoux, Nathalie
Piperno-Neumann, Sophie
Nemati, Fariba
Halilovic, Ensar
Jeay, Sebastien
Wylie, Andrew
Emery, Caroline
Roman-Roman, Sergio
Schoumacher, Marie
Decaudin, Didier
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3027
引用
收藏
页数：3
相关论文
共 44 条
  • [31] Dual Inhibition of Mdmx and Mdm2 Using an Alpha-Helical P53 Stapled Peptide (ALRN-6924) As a Novel Therapeutic Strategy in Acute Myeloid Leukemia
    Carvajal, Luis A.
    Ben-Neriah, Daniela
    Senecal, Adrien
    Bernard, Lumie
    Narayanagari, Swathi-Rao
    Kenworthy, Charles
    Thiruthuvanathan, Victor
    Guerlavais, Vincent
    Annis, D. Allen
    Bartholdy, Boris
    Will, Britta
    Anampa, Jesus
    Mantzaris, Ioannis
    Aivado, Manuel A.
    Singer, Robert H.
    Coleman, Robert
    Verma, Amit
    Steidl, Ulrich G.
    BLOOD, 2017, 130
  • [32] Phase 1 study of the p53-MDM2 inhibitor AMG 232 combined with trametinib plus dabrafenib or trametinib in patients (Pts) with TP53 wild type (TP53WT) metastatic cutaneous melanoma (MCM).
    Moschos, Stergios J.
    Sandhu, Shahneen Kaur
    Lewis, Karl D.
    Sullivan, Ryan J.
    Johnson, Douglas Buckner
    Zhang, Yilong
    Rasmussen, Erik
    Henary, Haby A.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells
    Patra, Tapas
    Meyer, Keith
    Ray, Ratna B.
    Kanda, Tatsuo
    Ray, Ranjit
    CELL DEATH & DISEASE, 2021, 12 (11)
  • [34] Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells
    Tapas Patra
    Keith Meyer
    Ratna B. Ray
    Tatsuo Kanda
    Ranjit Ray
    Cell Death & Disease, 12
  • [35] p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition
    Oppel, Felix
    Shao, Senyao
    Gendreizig, Sarah
    Zimmerman, Mark W.
    Schurmann, Matthias
    Flavian, Viyof Ful
    Goon, Peter
    Chi, Susan N.
    Aster, Jon C.
    Sudhoff, Holger
    Look, A. Thomas
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (11) : 1689 - 1700
  • [36] P7170: A Novel Molecule with Unique Profile of mTORC1/C2 and Activin Receptor-like Kinase 1 Inhibition Leading to Antitumor and Antiangiogenic Activity
    Jalota-Badhwar, Archana
    Bhatia, Dimple R.
    Boreddy, Srinivas
    Joshi, Asavari
    Venkatraman, Magesh
    Desai, Nikesh
    Chaudhari, Sarika
    Bose, Julie
    Kolla, Lakshmi S.
    Deore, Vijaykumar
    Yewalkar, Nilambari
    Kumar, Sanjay
    Sharma, Rajiv
    Damre, Anagha
    More, Avinash
    Sharma, Somesh
    Agarwal, Veena R.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (05) : 1095 - 1106
  • [37] Oryza sativa L. Indica Seed Coat Ameliorated Concanavalin A-Induced Acute Hepatitis in Mice via MDM2/p53 and PKCα/MAPK1 Signaling Pathways
    Zhao, Zhiye
    Li, Ye
    Guo, Shancheng
    Chen, Yuxu
    Yin, Haiaolong
    Li, Yaxian
    Cheng, Guiguang
    Tian, Lei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [38] Enhanced p53 Activation By Dual Inhibition of MDM2 and XPO1 Disrupts MYC Transcriptional Program and Restores Sensitivity to BCL-2 Inhibition in Ven/HMA Resistant AML
    Nishida, Yuki
    Ishizawa, Jo
    Ayoub, Edward
    Patsilevas, Tallie
    Ostermann, Lauren
    Montoya, Rafael Heinz
    Muftuoglu, Muharrem
    Ruvolo, Vivian
    Mak, Po Yee
    Tao, Wenjing
    Carter, Bing Z.
    Kojima, Kensuke
    Daver, Naval
    Lesegretain, Arnaud
    Seki, Takahiko
    Shacham, Sharon
    Konopleva, Marina
    Andreef, Michael
    BLOOD, 2021, 138
  • [39] P2X1 Receptor Inhibition and Soluble CD39 Administration as Novel Approaches to Widen the Cardiovascular Therapeutic Window
    Fung, C. Y. E.
    Marcus, Aaron J.
    Broekman, M. Johan
    Mahaut-Smith, Martyn P.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2009, 19 (01) : 1 - 5
  • [40] Dual Inhibition of MDM2 and XPO1 Induces Synergistic Apoptosis in Wild-type p53 Acute Myeloid Leukemia Through Nuclear Accumulation of p53 and Suppression of c-Myc
    Nishida, Yuki
    Ishizawa, Jo
    Ruvolo, Vivian
    Kojima, Kensuke
    Daver, Naval
    Lesegretain, Arnaud
    Shacham, Sharon
    Andreeff, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S215 - S215
12345